Skip to main content

Table 3 Comparison of median antibody levels of people with and without recent history of malaria and between the sexes (Group A- People with no history of disease within past 10 years, Group B-People with history of malaria disease within past 10 years) 293 individuals who stated ‘did not remember’ having a malaria attack were excluded in this specific analysis

From: Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka

 

Median anti-malarial antibody levels and total IgE levels (Q1-Q3) (International Units per microlitre except IgE levels measured in ng/mL)

Anti-AMA1_Pf

Anti-MSP1_Pf

Anti-MSP2_Pf

Anti-NANP_Pf

Total IgE

Anti- AMA1_Pv

Anti- MSP1_Pv

A (n = 532)

531.05

1450.15

1126.80

3390.35

4390.40

3356.15

2190.60

(211.96-1587.54)

(589.35-3092.42)

(516.52-2893.34)

(1878.68-6233.46)

(1850.20-8572.42)

(1407.27-9834.10)

(1113.22-5902.23)

B (n = 186)

885.10

1619.40

1492.45

4460.45

4163.30

3662.70

3559.70

(255.78-1972.92)

(603.70-3420.35)

(637.78-4450.73)

(2344.25-8624.20)

(1467.97-8258.32)

(1559.33-9297.81)

(1332.49-8794.58)

p value

0.004*

0.239

0.027*

0.002*

0.405

0.405

0.003*

Male (n = 353) (range)

592.43

1597.69

1340.89

3479.23

5719.66

3166.38

2386.78

(242.19-1701.04)

(673.87-3395.07)

(561.36-3324.04)

(2010.22-6952.50)

(2569.56-10853.45)

(1403.19-9701-93)

(1238.26-6724.18)

Female (n = 365) (range)

624.68

1501.08

1214.67

3585.46

3298.72

3691.38

2326.02

(200.56-1958.36)

(587.94-3349.18)

(519.17-3369.79)

(1913.57-6683.77)

(1189.41-5921.31)

(1591.25-10161.87)

(1122.44-6756.56)

p value

0.791

0.493

0.865

0.476

<0.001*

0.056

0.983

  1. Q1-Q3 (1st quartile-3rd quartile).
  2. Significant values [*Mann Whitney U test].